Invention Grant
- Patent Title: Compounds and compositions for treating EGFR expressing tumors
-
Application No.: US15110690Application Date: 2015-01-08
-
Publication No.: US10548985B2Publication Date: 2020-02-04
- Inventor: Lixin Li
- Applicant: BIRDIE BIOPHARMACEUTICALS, INC.
- Applicant Address: KY Grand Cayman
- Assignee: Birdie Biopharmaceuticals, Inc.
- Current Assignee: Birdie Biopharmaceuticals, Inc.
- Current Assignee Address: KY Grand Cayman
- Agency: K&L Gates LLP
- Agent Louis C. Cullman; David Diamond
- Priority: CN201410011262 20140110; CN201410011324 20140110; CN201410011362 20140110
- International Application: PCT/CN2015/070380 WO 20150108
- International Announcement: WO2015/103990 WO 20150716
- Main IPC: A61K47/68
- IPC: A61K47/68 ; C07K16/32 ; A61K45/06 ; A61K39/00
Abstract:
Provided are compounds for targeted immunotherapy. The compounds are useful in the treatment of EGFR expressing tumors/cancers. Also provided are compositions comprising the compounds.
Public/Granted literature
- US20160375148A1 Compounds and Compositions for Treating EGFR Expressing Tumors Public/Granted day:2016-12-29
Information query
IPC分类:
